Fetal Alcohol Syndrome

Fetal Alcohol Spectrum Disorder (FASD) encompasses a range of developmental and neurological sequelae resulting from maternal alcohol consumption during pregnancy, with Fetal Alcohol Syndrome (FAS) representing the most severe and completely characterized phenotype. FAS is characterized by the classic triad of prenatal/postnatal growth deficiency, facial dysmorphology, and central nervous system (CNS) dysfunction, occurring in approximately 0.5–2 per 1,000 live births in the United States with higher rates in certain populations. The condition represents the leading preventable cause of intellectual disability and developmental delay in developed nations. CNS involvement ranges from subtle neurodevelopmental delays to severe intellectual disability, with lifelong neurobehavioral consequences including attention-deficit/hyperactivity disorder (ADHD), learning disorders, and impulse control deficits. The neurological manifestations often persist into adulthood, resulting in significant morbidity and public health burden. Understanding FASD is essential for early identification and intervention, as evidence-based management can mitigate functional impairment.

Alcohol's teratogenic effects occur through multiple overlapping mechanisms that culminate in CNS malformation and permanent neurological dysfunction:

Ethanol and its metabolite acetaldehyde inhibit cell adhesion molecules (particularly N-cadherin) and disrupt microtubule dynamics, leading to abnormal neuronal migration during the critical window of neural tube closure (weeks 3–8 of gestation). Alcohol impairs retinoic acid signaling, a crucial pathway for hindbrain and midline CNS development. This results in malformations of the corpus callosum, cerebellum, anterior commissure, and basal ganglia—hallmark structural abnormalities in FAS. Reduced proliferation of neural progenitors occurs through suppression of fibroblast growth factor (FGF) signaling.

Ethanol metabolism by alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1) generates excessive reactive oxygen species (ROS) and depletes antioxidant reserves, particularly glutathione. This oxidative environment triggers excessive neuronal apoptosis during periods of rapid brain development. Activation of caspase-dependent apoptotic pathways results in permanent loss of neural tissue, explaining the structural microcephaly observed in FAS. The developing CNS is particularly vulnerable due to immature antioxidant defense systems and high metabolic demands.

Alcohol acts as an N-methyl-D-aspartate (NMDA) receptor antagonist, suppressing excitatory glutamatergic transmission acutely, followed by adaptive upregulation of NMDA and AMPA receptors. Upon cessation of alcohol exposure, unopposed glutamatergic signaling causes excitotoxic neuronal injury. Simultaneously, alcohol potentiates GABA(A) receptor function, leading to chronic suppression of inhibitory tone and subsequent compensatory downregulation of GABAergic signaling. This results in a persistent state of neuronal hyperexcitability and altered synaptic plasticity that persists postnatally, contributing to behavioral dysregulation, learning deficits, and seizure susceptibility.

Alcohol inhibits folate absorption and impairs dihydrofolate reductase activity, reducing 5-methyltetrahydrofolate availability for DNA synthesis and methylation reactions. Defective DNA methylation and altered histone acetylation patterns result in dysregulation of developmental gene expression, including genes encoding neurotrophic factors (particularly brain-derived neurotrophic factor [BDNF]) and genes controlling cell differentiation. Impaired methylation also affects genes regulating dopaminergic and serotonergic systems, explaining behavioral and mood abnormalities. These epigenetic changes can affect multiple generations through altered germline methylation patterns.

There is no established safe threshold for alcohol consumption during pregnancy. Risk escalates with dose, timing (first trimester carries highest risk for CNS and facial dysmorphology), and duration of exposure. Binge drinking (≥4 drinks per occasion) carries particular teratogenic risk. The developing embryo and fetus metabolize alcohol more slowly than maternal tissue, resulting in higher and more prolonged fetal blood alcohol concentrations. Chronic maternal consumption throughout pregnancy produces the most severe phenotype.

Advanced maternal age, poor nutritional status (particularly folate, thiamine, and zinc deficiency), presence of alcoholic liver disease (impaired alcohol metabolism), comorbid psychiatric disorders, low socioeconomic status, and lack of prenatal care all increase FASD severity. Genetic polymorphisms in maternal alcohol metabolizing enzymes (ADH1B, ADH1C, CYP2E1) influence the rate of ethanol oxidation and consequently fetal exposure. Maternal homozygous MTHFR C677T mutations may increase vulnerability to folate-related teratogenicity. Use of concurrent teratogens (tobacco, illicit drugs, certain medications) compounds CNS injury through additive oxidative stress and disrupted neurodevelopment.

Microcephaly (head circumference <3rd percentile, often severe), hypotonia progressing to hypertonia, tremulousness and irritability, poor feeding and weak suck, seizures (in severely affected infants), and developmental delay evident by 6–12 months. Neonatal abstinence syndrome manifestations may overlap with direct alcohol teratogenicity.

Short palpebral fissures (<3rd percentile in length) represent the most consistent facial finding. Smooth philtrum (absent ridging between nose and upper lip), thin vermillion border of upper lip (appearing as a narrow red line), micrognathia or retrognathia, short nose with hypoplastic nasal bridge, low-set ears, and microtia. Midface hypoplasia creates characteristic appearance of a small, flat face. These features are most apparent in early childhood and may become less pronounced with age. Findings reflect disrupted neural crest cell development during the critical period of facial morphogenesis (weeks 6–9).

Intrauterine growth restriction (birth weight typically <10th percentile) and failure to thrive in infancy despite adequate caloric intake. Height and weight remain <10th percentile into childhood and adulthood. Postnatal catch-up growth typically does not occur. Growth hormone deficiency has been reported in some cases, though malnutrition and feeding difficulties contribute substantially.

Intellectual disability (ranging from mild to severe, with mean IQ reduction of 30 points), ADHD with marked impulsivity and hyperactivity, learning disabilities affecting mathematics and reading, behavioral dysregulation with poor impulse control and inappropriate social behavior, difficulty with abstract reasoning and executive function. Specific math learning disorder is characteristic. Poor adaptive functioning despite measured IQ, suggesting executive dysfunction beyond intellectual capacity. Fine and gross motor delays, poor coordination and balance (cerebellar involvement), and increased risk of seizure disorders (up to 60% develop seizures by adulthood).

Depression, anxiety disorders, reactive attachment disorder, poor peer relationships and social isolation, oppositional defiant disorder (ODD), conduct disorder, and increased risk of substance abuse in adolescence/adulthood. Personality changes including emotional lability, aggression, and poor judgment contribute to significant functional impairment.

Cardiac defects (atrial or ventricular septal defects, tetralogy of Fallot) occur in ~50% of FAS cases. Renal anomalies (dysplasia, hypoplasia, hydronephrosis), skeletal abnormalities (scoliosis, vertebral fusion, radioulnar synostosis, limited hip abduction), hearing loss (conductive or sensorineural), ophthalmologic abnormalities (strabismus, refractive errors, optic nerve hypoplasia, anterior chamber abnormalities).

Continued intellectual disability and neurocognitive deficits, increased vulnerability to mental illness, substance use disorders (approximately 4-fold increased risk), legal involvement, difficulties with independent living and employment. Increased mortality from accidents, suicide, and alcohol-related complications in those with undiagnosed FASD who develop secondary alcoholism.

The diagnosis integrates four essential components:

Detailed maternal history documenting quantity, frequency, and timing of alcohol consumption during pregnancy. Biomarkers of fetal alcohol exposure include phosphatidylethanol (PEth) in meconium (persists 3–4 weeks postpartum) and fatty acid ethyl esters (FAEEs) in meconium. Maternal medical records, collateral history from family members, and documentation of maternal alcohol use disorder diagnoses support confirmation. Absence of confirmed exposure does not exclude diagnosis (partial FAS or alcohol-related neurodevelopmental disorder [ARND]).

Height and/or weight ≤10th percentile for age (or documented growth deficiency at birth). Prenatal growth restriction documented by obstetric records or decreased birth weight (<2500 g at term). Growth parameters assessed throughout childhood demonstrate persistent deficit rather than temporary neonatal effect.

Short palpebral fissures (≤10th percentile for age), smooth philtrum (scored 4–5 on 5-point scale), and thin upper lip vermillion (scored 4–5 on 5-point scale). These are assessed using standardized measurement techniques and comparison with age-specific normative data. Photography with standardized angles aids documentation. Features may be subtle in older children/adults as facial growth occurs; reassessment at different ages may be necessary.

Structural CNS abnormalities documented on neuroimaging (MRI preferred over CT):

Functional/Neurodevelopmental CNS impairment documented through:

MRI Brain (gold standard):

CT less sensitive but shows microcephaly and severe structural malformations. Functional MRI reveals abnormal activation patterns in prefrontal cortex during executive function tasks (correlates with behavioral dysregulation).

Early intervention services through state programs (mandated under IDEA Part C) provide intensive speech-language pathology, occupational therapy, physical therapy, and developmental psychology services. Frequency ideally 2–5 sessions weekly targeting motor delays, oral-motor dysfunction affecting feeding, and emerging developmental delays. Family-centered practice with parent coaching for home programming maximizes neuroplasticity benefits. Nutritional support and management of feeding difficulties (occupational/speech therapy, possible feeding tube placement if severe) to address failure to thrive. Auditory and visual assessment and management of identified sensory deficits.

Individualized Education Plans (IEP) under IDEA guarantee special education services including resource room support, modifications (extended time, reduced distractions), and accommodations (preferential seating, frequent breaks). 504 Plans provide accessible alternative if child does not qualify for special education. Structured classroom environment with clear, consistent routines, visual schedules, and limited distractions maximizes attention and behavioral regulation. Direct instruction in executive function skills (organization, planning, time management) with external supports (written reminders, checklists, visual timers).

Parent-Child Interaction Therapy (PCIT) for preschool-age children teaches caregivers evidence-based behavior management strategies (positive reinforcement, consistent boundaries, strategic ignoring of minor misbehaviors) to reduce oppositional behaviors and improve parent-child relationship. Cognitive-behavioral therapy (CBT) adapted for developmental level helps older children identify triggers for behavioral dysregulation and practice coping strategies. Contingency management systems (token economies, point systems) provide external structure and immediate reinforcement for target behaviors. Social skills training groups address peer relationship deficits and teach pragmatic communication. Consistency across home and school settings critical for success.

Stimulant medications (methylphenidate, amphetamine preparations) address ADHD symptoms including inattention, hyperactivity, and impulsivity with moderate efficacy. Atomoxetine (selective norepinephrine reuptake inhibitor) provides alternative if stimulants ineffective or contraindicated. Guanfacine or clonidine (alpha